NCT06437132 · RECRUITING

Decoding Death and Dying in People With Dementia by Digital Thanotyping

This study is not testing a treatment. Researchers are using wearable sensors and clinical assessments to monitor nursing home residents with dementia, hoping to identify patterns that signal when someone is entering the final phase of life — what they call the point of no return. The goal is to build better tools for recognizing dying earlier and more accurately. This is observational research, not a drug or therapy trial.

You may qualify if

  • Nursing home resident
  • >64 years old
  • People with dementia or who have a likely diagnosis of dementia
  • Score of \<4 on the 4 A's Test for Delirium (4AT) will be required for inclusion (no delirium)

You're excluded if

  • People without dementia or cognitive impairment
  • People that are considered already in a health status emergency (\< 6 weeks to live)
  • People that are not living in the nursing home
  • People without informed/presumed consent

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-05-31

View full record on ClinicalTrials.gov

All APOE4 clinical trials